Gerald William Smetana, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Teaching Rounds | 12 | 2024 | 280 | 4.000 |
Why?
|
Perioperative Care | 15 | 2018 | 1055 | 2.590 |
Why?
|
Lung Diseases | 12 | 2016 | 1940 | 1.430 |
Why?
|
Practice Guidelines as Topic | 17 | 2024 | 7425 | 1.140 |
Why?
|
Preoperative Care | 10 | 2015 | 2267 | 1.010 |
Why?
|
Postoperative Complications | 19 | 2017 | 15747 | 0.860 |
Why?
|
Drugs, Investigational | 3 | 2010 | 211 | 0.860 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3110 | 0.740 |
Why?
|
Early Detection of Cancer | 3 | 2019 | 3236 | 0.630 |
Why?
|
Prostatic Hyperplasia | 1 | 2023 | 515 | 0.630 |
Why?
|
Asymptomatic Diseases | 3 | 2017 | 586 | 0.630 |
Why?
|
Guideline Adherence | 4 | 2019 | 2243 | 0.620 |
Why?
|
Cannabinoids | 1 | 2021 | 174 | 0.610 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2022 | 3251 | 0.590 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12240 | 0.560 |
Why?
|
Diabetic Neuropathies | 1 | 2021 | 408 | 0.550 |
Why?
|
Triamterene | 1 | 2016 | 4 | 0.520 |
Why?
|
Mass Screening | 3 | 2017 | 5446 | 0.520 |
Why?
|
Risk Assessment | 21 | 2022 | 24282 | 0.510 |
Why?
|
Drug Approval | 2 | 2016 | 818 | 0.510 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2013 | 193 | 0.490 |
Why?
|
Hypogonadism | 1 | 2021 | 801 | 0.480 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2018 | 399 | 0.470 |
Why?
|
Urinalysis | 2 | 2015 | 368 | 0.460 |
Why?
|
Hematocrit | 1 | 2015 | 621 | 0.440 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2013 | 33 | 0.430 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1090 | 0.420 |
Why?
|
Respiratory Function Tests | 3 | 2015 | 1693 | 0.410 |
Why?
|
Thyroxine | 1 | 2016 | 672 | 0.400 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 3247 | 0.400 |
Why?
|
Heart Diseases | 3 | 2016 | 2821 | 0.400 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2016 | 1237 | 0.400 |
Why?
|
Anti-Obesity Agents | 1 | 2016 | 242 | 0.400 |
Why?
|
Cardiovascular Diseases | 10 | 2022 | 15652 | 0.390 |
Why?
|
Potassium | 1 | 2016 | 1311 | 0.370 |
Why?
|
Hypertension | 4 | 2018 | 8626 | 0.370 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1880 | 0.360 |
Why?
|
Hypothyroidism | 1 | 2016 | 667 | 0.360 |
Why?
|
Bone Density Conservation Agents | 1 | 2018 | 791 | 0.360 |
Why?
|
Prediabetic State | 1 | 2016 | 548 | 0.350 |
Why?
|
Humans | 79 | 2024 | 765968 | 0.350 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 753 | 0.350 |
Why?
|
Anticoagulants | 4 | 2016 | 4862 | 0.350 |
Why?
|
Testosterone | 1 | 2021 | 2494 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2310 | 0.350 |
Why?
|
Review Literature as Topic | 1 | 2012 | 297 | 0.340 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2012 | 216 | 0.340 |
Why?
|
Carotid Stenosis | 1 | 2017 | 861 | 0.340 |
Why?
|
Pleural Cavity | 1 | 2010 | 27 | 0.340 |
Why?
|
Drug Therapy | 1 | 2013 | 504 | 0.340 |
Why?
|
Patient Care | 1 | 2015 | 629 | 0.330 |
Why?
|
Blood Pressure | 2 | 2018 | 8532 | 0.330 |
Why?
|
Paracentesis | 1 | 2010 | 99 | 0.330 |
Why?
|
Prostate-Specific Antigen | 1 | 2019 | 2464 | 0.330 |
Why?
|
Primary Health Care | 4 | 2015 | 4736 | 0.320 |
Why?
|
Surgical Procedures, Operative | 7 | 2017 | 1941 | 0.320 |
Why?
|
Antihypertensive Agents | 3 | 2018 | 2033 | 0.320 |
Why?
|
Atrial Fibrillation | 4 | 2019 | 5189 | 0.310 |
Why?
|
Bariatric Surgery | 2 | 2017 | 997 | 0.310 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2013 | 453 | 0.310 |
Why?
|
Family Practice | 2 | 2013 | 508 | 0.310 |
Why?
|
Clinical Medicine | 1 | 2010 | 145 | 0.300 |
Why?
|
Weight Loss | 2 | 2017 | 2710 | 0.290 |
Why?
|
Patient Selection | 1 | 2019 | 4255 | 0.280 |
Why?
|
Exercise Test | 1 | 2015 | 2180 | 0.280 |
Why?
|
Genetic Testing | 1 | 2020 | 3595 | 0.280 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2018 | 2770 | 0.280 |
Why?
|
Hypercalcemia | 1 | 2010 | 426 | 0.270 |
Why?
|
Electrocardiography | 3 | 2016 | 6404 | 0.260 |
Why?
|
Pneumothorax | 1 | 2010 | 392 | 0.260 |
Why?
|
Cholesterol | 1 | 2015 | 2898 | 0.260 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1292 | 0.260 |
Why?
|
Risk Factors | 19 | 2022 | 74840 | 0.250 |
Why?
|
Internal Medicine | 4 | 2019 | 1064 | 0.250 |
Why?
|
Respiratory Insufficiency | 4 | 2006 | 1240 | 0.240 |
Why?
|
Formularies as Topic | 1 | 2004 | 93 | 0.230 |
Why?
|
Radiography | 1 | 2015 | 6919 | 0.230 |
Why?
|
Drainage | 1 | 2010 | 1179 | 0.220 |
Why?
|
Cardiac Imaging Techniques | 2 | 2010 | 280 | 0.220 |
Why?
|
Clinical Competence | 3 | 2015 | 4863 | 0.220 |
Why?
|
Electroconvulsive Therapy | 1 | 2009 | 506 | 0.220 |
Why?
|
Patient Care Team | 1 | 2014 | 2517 | 0.210 |
Why?
|
Cardiology | 5 | 2015 | 1702 | 0.210 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2023 | 170 | 0.210 |
Why?
|
Aged | 17 | 2023 | 171117 | 0.210 |
Why?
|
Warfarin | 1 | 2011 | 1494 | 0.200 |
Why?
|
Specialization | 1 | 2007 | 777 | 0.190 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2023 | 114 | 0.190 |
Why?
|
Hemorrhage | 1 | 2013 | 3461 | 0.190 |
Why?
|
Obesity | 4 | 2019 | 13076 | 0.180 |
Why?
|
Oxidoreductases | 1 | 2023 | 409 | 0.180 |
Why?
|
Diabetic Foot | 1 | 2024 | 384 | 0.170 |
Why?
|
Ticlopidine | 2 | 2018 | 731 | 0.170 |
Why?
|
Medical History Taking | 2 | 2002 | 777 | 0.170 |
Why?
|
Drug Therapy, Combination | 3 | 2023 | 6309 | 0.170 |
Why?
|
Male | 18 | 2024 | 363698 | 0.170 |
Why?
|
Heart Failure | 1 | 2023 | 11840 | 0.160 |
Why?
|
Bone and Bones | 1 | 2010 | 2554 | 0.160 |
Why?
|
Psoas Abscess | 1 | 1999 | 11 | 0.160 |
Why?
|
Spirometry | 3 | 2009 | 929 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 4 | 2015 | 20659 | 0.150 |
Why?
|
Fusobacterium Infections | 1 | 1999 | 54 | 0.150 |
Why?
|
Medicine | 1 | 2007 | 942 | 0.150 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2184 | 0.150 |
Why?
|
Patients | 1 | 2004 | 910 | 0.150 |
Why?
|
Hospitalization | 2 | 2024 | 10808 | 0.150 |
Why?
|
Headache Disorders | 1 | 2000 | 152 | 0.150 |
Why?
|
United States | 11 | 2022 | 72903 | 0.150 |
Why?
|
Treatment Outcome | 6 | 2023 | 65188 | 0.140 |
Why?
|
Giant Cell Arteritis | 1 | 2002 | 302 | 0.140 |
Why?
|
Fusobacterium nucleatum | 1 | 1999 | 176 | 0.140 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 969 | 0.140 |
Why?
|
Gender Identity | 1 | 2023 | 766 | 0.140 |
Why?
|
Administration, Inhalation | 1 | 2020 | 1154 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 1 | 2003 | 790 | 0.140 |
Why?
|
Alendronate | 1 | 2018 | 174 | 0.140 |
Why?
|
Referral and Consultation | 2 | 2020 | 3615 | 0.140 |
Why?
|
Primary Prevention | 2 | 2022 | 1187 | 0.130 |
Why?
|
Genetic Counseling | 1 | 2020 | 634 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11083 | 0.130 |
Why?
|
Metformin | 1 | 2024 | 904 | 0.130 |
Why?
|
Smoking Cessation | 3 | 2014 | 2084 | 0.130 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6544 | 0.130 |
Why?
|
Coffee | 1 | 2020 | 593 | 0.130 |
Why?
|
Female | 16 | 2023 | 396112 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2233 | 0.120 |
Why?
|
Echocardiography, Stress | 1 | 2016 | 137 | 0.120 |
Why?
|
Methods | 1 | 2015 | 1052 | 0.120 |
Why?
|
Age Factors | 5 | 2014 | 18380 | 0.120 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 2531 | 0.120 |
Why?
|
Pain | 1 | 2010 | 5077 | 0.120 |
Why?
|
Risk Reduction Behavior | 3 | 2015 | 1123 | 0.110 |
Why?
|
Urology | 1 | 2019 | 384 | 0.110 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2017 | 490 | 0.110 |
Why?
|
Postoperative Care | 4 | 2009 | 1470 | 0.110 |
Why?
|
Middle Aged | 11 | 2023 | 223009 | 0.110 |
Why?
|
Intraoperative Care | 2 | 2009 | 760 | 0.110 |
Why?
|
Myocardial Infarction | 2 | 2013 | 11499 | 0.110 |
Why?
|
Analgesics | 1 | 2021 | 1060 | 0.110 |
Why?
|
Alzheimer Disease | 1 | 2015 | 8730 | 0.110 |
Why?
|
Clonidine | 1 | 2014 | 165 | 0.110 |
Why?
|
Quality of Health Care | 3 | 2009 | 4300 | 0.110 |
Why?
|
Diet, Reducing | 1 | 2017 | 487 | 0.110 |
Why?
|
Preoperative Period | 1 | 2016 | 566 | 0.110 |
Why?
|
Arizona | 1 | 2013 | 108 | 0.110 |
Why?
|
Diphosphonates | 1 | 2018 | 625 | 0.110 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1180 | 0.110 |
Why?
|
Osteoporotic Fractures | 1 | 2018 | 415 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2017 | 929 | 0.100 |
Why?
|
Benchmarking | 2 | 2009 | 1052 | 0.100 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2393 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12976 | 0.100 |
Why?
|
Diuretics | 1 | 2016 | 613 | 0.100 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2012 | 85 | 0.100 |
Why?
|
Hypoglycemia | 1 | 2019 | 896 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 557 | 0.100 |
Why?
|
Absorptiometry, Photon | 1 | 2018 | 1707 | 0.100 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2017 | 1896 | 0.090 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3685 | 0.090 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21056 | 0.090 |
Why?
|
Smoking | 3 | 2020 | 9081 | 0.090 |
Why?
|
Cooperative Behavior | 2 | 2012 | 1509 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3928 | 0.090 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13451 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4850 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2017 | 937 | 0.090 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2016 | 669 | 0.080 |
Why?
|
Insulin | 1 | 2024 | 6599 | 0.080 |
Why?
|
Blood Glucose | 1 | 2024 | 6424 | 0.080 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1061 | 0.080 |
Why?
|
Stroke Volume | 1 | 2023 | 5596 | 0.080 |
Why?
|
Breast | 1 | 2018 | 1946 | 0.080 |
Why?
|
Drug-Eluting Stents | 2 | 2017 | 683 | 0.080 |
Why?
|
Hypertension, Pulmonary | 2 | 2011 | 1604 | 0.080 |
Why?
|
Systole | 1 | 2011 | 935 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15398 | 0.080 |
Why?
|
Diastole | 1 | 2011 | 785 | 0.080 |
Why?
|
Adult | 9 | 2021 | 223044 | 0.080 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1149 | 0.080 |
Why?
|
Mammography | 1 | 2018 | 2423 | 0.070 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 647 | 0.070 |
Why?
|
Odds Ratio | 2 | 2009 | 9649 | 0.070 |
Why?
|
Quinoxalines | 1 | 2008 | 296 | 0.070 |
Why?
|
Thiophenes | 1 | 2011 | 569 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2015 | 1944 | 0.070 |
Why?
|
Benzazepines | 1 | 2008 | 308 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 3 | 2006 | 747 | 0.070 |
Why?
|
Heart Function Tests | 1 | 2007 | 317 | 0.070 |
Why?
|
Blood Transfusion | 1 | 2013 | 1297 | 0.070 |
Why?
|
Patient Participation | 1 | 2015 | 1455 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1394 | 0.060 |
Why?
|
Bone Density | 1 | 2018 | 3491 | 0.060 |
Why?
|
Drug Costs | 1 | 2013 | 1193 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2017 | 3714 | 0.060 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2009 | 581 | 0.060 |
Why?
|
Heart Arrest | 1 | 2014 | 1516 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1736 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5993 | 0.060 |
Why?
|
Aspirin | 2 | 2018 | 3134 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1727 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2009 | 2910 | 0.060 |
Why?
|
Health Policy | 1 | 2016 | 2698 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2014 | 2098 | 0.050 |
Why?
|
Health Expenditures | 1 | 2016 | 2387 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3242 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10383 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2009 | 3675 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2009 | 1172 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3529 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3782 | 0.050 |
Why?
|
Colectomy | 1 | 2007 | 697 | 0.050 |
Why?
|
Memory Disorders | 1 | 2009 | 1194 | 0.050 |
Why?
|
Hematologic Tests | 1 | 2003 | 239 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2014 | 1882 | 0.050 |
Why?
|
Liver Function Tests | 1 | 2003 | 525 | 0.050 |
Why?
|
Telephone | 1 | 2004 | 627 | 0.050 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1462 | 0.050 |
Why?
|
Blood Sedimentation | 1 | 2002 | 233 | 0.040 |
Why?
|
Health Services Misuse | 1 | 2003 | 245 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2003 | 683 | 0.040 |
Why?
|
Comorbidity | 2 | 2007 | 10563 | 0.040 |
Why?
|
Piperazines | 1 | 2011 | 2549 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5526 | 0.040 |
Why?
|
Thromboembolism | 1 | 2006 | 1003 | 0.040 |
Why?
|
Cluster Headache | 1 | 2000 | 54 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3424 | 0.040 |
Why?
|
Tension-Type Headache | 1 | 2000 | 76 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 13039 | 0.040 |
Why?
|
Managed Care Programs | 1 | 2004 | 934 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1162 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2004 | 1668 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13632 | 0.040 |
Why?
|
Societies, Medical | 1 | 2009 | 3956 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2017 | 59489 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2006 | 1327 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2004 | 1084 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 251 | 0.030 |
Why?
|
Coronary Disease | 1 | 2010 | 5912 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2003 | 1315 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2002 | 999 | 0.030 |
Why?
|
Sex Factors | 1 | 2010 | 10603 | 0.030 |
Why?
|
Physical Examination | 1 | 2002 | 1266 | 0.030 |
Why?
|
Stroke | 1 | 2017 | 9747 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9591 | 0.030 |
Why?
|
Delirium | 1 | 2006 | 1707 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2002 | 1219 | 0.030 |
Why?
|
Psychotic Disorders | 1 | 2009 | 3270 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2017 | 487 | 0.030 |
Why?
|
Decision Making | 1 | 2007 | 3965 | 0.030 |
Why?
|
Frail Elderly | 1 | 2017 | 785 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 714 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2009 | 5138 | 0.020 |
Why?
|
Analgesia | 2 | 2006 | 461 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3278 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12056 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4808 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 29922 | 0.020 |
Why?
|
Biopsy | 1 | 2002 | 6763 | 0.020 |
Why?
|
Health Status | 1 | 2003 | 4080 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 932 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20124 | 0.020 |
Why?
|
Psychotherapy | 1 | 2017 | 1645 | 0.020 |
Why?
|
Lung | 1 | 2006 | 10033 | 0.020 |
Why?
|
Low Back Pain | 1 | 2016 | 987 | 0.020 |
Why?
|
Migraine Disorders | 1 | 2000 | 1732 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2017 | 1434 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1175 | 0.020 |
Why?
|
Anesthesia | 2 | 2006 | 1590 | 0.010 |
Why?
|
American Heart Association | 1 | 2009 | 1047 | 0.010 |
Why?
|
Asthma | 1 | 2003 | 6270 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2014 | 1946 | 0.010 |
Why?
|
Cohort Studies | 1 | 2004 | 41649 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10850 | 0.010 |
Why?
|
Prospective Studies | 1 | 2004 | 54802 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4058 | 0.010 |
Why?
|
Mentors | 1 | 2002 | 671 | 0.010 |
Why?
|
Animals | 1 | 2008 | 168764 | 0.010 |
Why?
|
Clinical Clerkship | 1 | 2002 | 568 | 0.010 |
Why?
|
Laparoscopy | 1 | 2006 | 2039 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2002 | 2780 | 0.010 |
Why?
|